OSL Insider Trading

Insider Ownership Percentage: 17.44%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$63,692.32

OncoSil Medical Insider Trading History Chart

This chart shows the insider buying and selling history at OncoSil Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OncoSil Medical Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for OSL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

OncoSil Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/30/2023Otto ButtulaInsiderSell5,307,693A$0.01A$63,692.32
5/11/2023Nigel LangeInsiderIssued1,000,000A$0.01A$10,000.00
2/28/2023Ricky SharmaInsiderCancelled3,540,146A$0.04A$123,905.11
11/24/2022Otto ButtulaInsiderIssued3,000,000A$0.05A$150,000.00
11/4/2022Brian LeedmanInsiderBuy927,975A$0.05A$44,542.80
10/25/2022Ricky SharmaInsiderIssued4,000,000A$0.05A$200,000.00
6/10/2022Nigel LangeInsiderIssued500,000A$0.05A$25,000.00
10/20/2021Nigel LangeInsiderIssued2,841,633A$0.05A$153,448.18
8/24/2021Martin CrossInsiderBuy95,000A$0.05A$4,845.00
5/10/2021Christopher RobertsInsiderCancelled10,000,000A$0.09A$900,000.00
12/18/2020Roger AstonInsiderCancelled500,000A$0.13A$65,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for OncoSil Medical (ASX:OSL)

2.45% of OncoSil Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Read More on OncoSil Medical

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


2,172,618 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of OncoSil Medical?

OncoSil Medical's top insider shareholders include:
  1. Brian Leedman (Insider)
  2. Nigel Lange (Insider)
  3. Otto Buttula (Insider)
  4. Ricky Sharma (Insider)
Learn More about top insider investors at OncoSil Medical.